Nanoparticle-Enhanced Radiotherapy Synergizes with PD-L1 Blockade to Limit Post-surgical Cancer Recurrence and Metastasis

Researchers demonstrated that the genomic landscape shaped by surgical resection created an immunosuppressive milieu characterized by hypoxia and high-influx of myeloid cells, fostering cancer progression and hindering PD-L1 blockade therapy.